Clin2
NCT01186913Worth exploringEnrolling by invitation

Natural history study for severe combined immune deficiency (SCID)

Severe Combined Immunodeficiency (SCID)Leaky SCIDOmenn SyndromeReticular DysgenesisADA SCIDXSCID

Part of Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.

This study follows children and adults with SCID and related immune disorders to understand how the illness behaves over time. It also helps researchers learn which testing results and genetic types of SCID match different treatment plans.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
690 people
Ages
Any age
Study type
Observational

Who can take part

  • You (or your child) have SCID or a related condition that doctors classify as one of the SCID “types” the study studies
  • Blood testing shows the T-cell immune part is missing or severely weak (the exact lab cutoffs depend on the SCID type)
  • Your doctor plans a specific SCID treatment path (for example, transplant, PEG-ADA replacement medicine, or gene therapy)
  • If this is “typical” SCID: either T cells are very low, T-cell function is very low, or T cells came from the mother
  • If this is Omenn syndrome or “leaky” SCID: specific lab and symptoms (like rash for Omenn) and maternal cell testing must fit the study’s rules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06851767Enrolling by invitation· Phase 1/Phase 2
Gene therapy for X-linked severe combined immunodeficiency

This trial tests a gene therapy that uses base-edited stem cells to treat X-SCID, a genetic immune disorder. It may help improve immune function and reduce infections in patients who still have low immune cells or severe infections despite previous treatments.

Bethesda, Maryland
NCT07284641Recruiting· Phase 2
Stem cell transplant for immune disorders

This trial tests a stem cell transplant to treat common variable immunodeficiency (CVID) and other immune problems. It aims to replace a faulty immune system with a healthy one from a donor.

Pittsburgh, Pennsylvania
NCT01852370Enrolling by invitation· Phase 1/Phase 2
Lung and bone marrow transplant plan for immune system disorders

This early-phase study tests a step-by-step transplant approach: first replacing the lungs, then doing a bone marrow (stem cell) transplant to treat certain immune deficiency diseases. It may help people whose immune problem has led to severe, end-stage lung disease.

Pittsburgh, Pennsylvania
NCT06659588Recruiting
Study of chronic hepatitis risk in people with immune weaknesses

This study looks at people with certain immune system weaknesses to see if they are at risk for chronic hepatitis caused by a virus in the gut. Researchers want to understand how the immune system affects this infection.

Paris
NCT07704281Not yet recruiting
Long-term follow-up for babies with abnormal immune screening

This study follows babies who had an abnormal newborn screening for severe immune problems. It aims to track their health over time.

Nantes
NCT00128973Recruiting
Study immune system problems in people with unusual infections

This study looks at how the immune system works in people who have abnormal immune function, often shown by unusual or repeated infections or long-lasting inflammation. It may involve tests using blood samples and storage of blood for future research.

Bethesda, Maryland

Hear when a new Severe Combined Immunodeficiency (SCID) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.